跳至主要内容
临床试验/DRKS00009770
DRKS00009770已完成未知

Effect of multimicronutrient supplementation on vitamin D status in women of childbearing age - BTS917/15

Merck Selbstmedikation GmbH0 个研究点目标入组 201 人开始时间: 2016年1月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
201

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • 1)Subject is able and willing to sign the Informed Consent Form prior to screening evaluations
  • 2)Healthy volunteers: Subject is in good physical and mental health as established by medical history, physical examination, vital signs, results of biochemistry and haematology
  • 3)Women of childbearing age
  • 4)Age = 18 and = 45 years
  • 5)BMI: 17-30 kg/m2
  • 6)No travel into southern countries in the past 30 days
  • 7)No plans to travel into southern countries during the study
  • 8)Able and willing to follow the study protocol procedures

排除标准

  • 1)For this study clinically relevant abnormal, vital signs or physical findings at screening and abnormal laboratory finding at visit 1
  • 2)Taking any medication interfering with vitamin D metabolism, e.g. cardiac glycosides, barbitu-rates, anti-tuberculosis drugs (rifampicin, isoniazid), cholestyramine, glucocorticoids (except inhalative), benzothiadiazine derivates, anti-convulsants, PTH or PTH derivates in the past 6 months
  • 3)Vitamin D prescription
  • 4)Intake of the antibiotics Pyrimethamin or Trimethoprim two weeks prior to visit 1 as both anti-biotics interfere with the folate metabolism.
  • 5)Taking other dietary supplements/medication with folate and/or vitamin D in the past 2 months.
  • 6)Concomitant use of cod liver oil or intake during the past 2 months
  • 7)Because of thyroid disorder intake of iodine contraindicated
  • 8)Sarcoidosis or any other granuloma-forming inflammatory disease
  • 9)Osteoporosis, Osteomalacia
  • 10)History of diabetes, stroke, CVD, cancer
  • 11)Fat malabsorption (Crohn’s or celiac disease, cystic fibrosis)
  • 12)Gastrointestinal diseases/conditions (colitis ulcerosa, Crohn’s IBS, IBD, peptic ulcers) hinder-ing Vit. D absorption
  • 13)Liver or renal disease (including alcoholism)
  • 14)Pancreatic insufficiency (disturbed fat metabolism)
  • 15)Ca kidney stones or history of hypercalcaemia and hypercalciuria
  • 16)Psychological disorders
  • 17)Calcium metabolism disorders
  • 18)Hypo-& and Hyperparathyroidism
  • 19)Participants anticipating a change in their lifestyle or physical activity levels during the study.
  • 20)Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study.
  • 21)Known hypersensitivity to the study preparation or to single ingredients (e.g. allergy to crus-taceans or fish)
  • 22)Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject.
  • 23)Known HIV-infection
  • 24)Known acute or chronic hepatitis B and C infection
  • 25)Blood donation within 4 weeks prior to visit 1 or during the study.
  • 26)Subject involved in any clinical or food study 4 weeks prior to visit 1

研究者

相似试验